2024-02-08 05:05:15 ET
Summary
- Inspire Medical Systems reported a surprising profit of 49 cents per share, beating analyst estimates who were expecting it to report a loss.
- The company's YoY revenue growth has slowed to about 40% and expected to further slow down to 25% next year based on guidance.
- It is still expected to see double digit growth for many years to come with possible international expansion.
- INSP stock trades at a premium of 10x revenues of 115 times profits and it could use a pullback.
Inspire Medical Systems ( INSP ) released its latest earnings report representing Q4 and full year of 2023 in the after hours of February 6th. The medical device company posted a surprising profit of 49 cents per share on revenues of $192.5 million (representing a growth of 39.6%), easily beating analyst estimates of a loss of 6 cents per share. The results also indicated a strong earnings growth as compared to net income of 10 cents per share in the same quarter a year ago, representing a growth rate of 390% for the next income....
Read the full article on Seeking Alpha
For further details see:
Inspire Medical Systems: Strong Q4 Results But Growth Might Be Slowing